InvestorsHub Logo
Followers 73
Posts 17578
Boards Moderated 0
Alias Born 09/03/2001

Re: None

Thursday, 09/27/2018 3:14:08 PM

Thursday, September 27, 2018 3:14:08 PM

Post# of 346050
Bavi rectal carcinoma trial

https://www.mdlinx.com/journal-summaries/bavituximab-toxicity-radiation-therapy-rectal-adenocarcinoma/2018/09/27/7545298/?spec=oncology

Findings indicated the safety of bavituximab in combination with capecitabine and radiation therapy at the doses selected for the study. A grade III infusion reaction related to bavituximab was experienced by one patient at the highest dose level. A complete pathologic response to the combination treatment was seen in one tumor.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News